內部人士可能會獲得普通股東無法享受的可觀財務利益。
擬議的交易可能包含限制更優競爭報價的條款。
鼓勵股東與本公司聯繫，討論他們的權利和選擇，且無需支付任何費用或義務。我們將以風險代理的方式處理任何事務，您無需承擔我們的法律費用或開支。
紐約
2026 年 5 月 12 日
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) 以每股 31.50 美元現金出售給 Angelini Pharma S.p.A. 如果您是 Catalyst 的股東， 請點擊這裏瞭解您的權利和選擇 。
UniFirst Corporation (NYSE: UNF) 以每股 155.00 美元現金和 0.7720 股 Cintas 股票出售給 Cintas Corporation。如果您是 UniFirst 的股東， 請點擊這裏瞭解您的權利和選擇 。
RE/MAX Holdings, Inc. (NYSE: RMAX) 以每股 5.152 股合併公司的股票或每股 13.80 美元現金出售給 The Real Brokerage Inc. 如果您是 RE/MAX 的股東， 請點擊這裏瞭解您的權利和選擇 。
ACRES Commercial Realty Corp. (NYSE: ACR) 與 ACRES Capital Corp. 合併。如果您是 ACRES Commercial 的股東， 請點擊這裏瞭解您的法律權利和選擇。
代表股東，Halper Sadeh LLC 可能尋求增加對價、額外披露和信息，或其他救濟和利益。
Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
律師廣告。以往的結果並不保證類似的結果。
聯繫信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
世界貿易中心一號
85 層
紐約，NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
來源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU2UFJfTkVXU19VU1BSX19fX19OWTU3MDY0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU2UFJfTkVXU19VU1BSX19fX19OWTU3MDY0"/>

觸媒制藥公司

RE/MAX控股

Halper Sadeh LLC 正在調查 Catalyst Pharmaceuticals、UniFirst Corporation、RE/MAX Holdings 和 ACRES Commercial Realty 是否存在違反聯邦證券法的潛在行為。該公司暗示內部人士可能會在普通股東的利益受損的情況下獲得財務利益。他們鼓勵股東無償討論自己的權利和選擇。這些調查與涉及這些公司的擬議銷售和合並有關，該公司代表股東尋求增加對價和披露信息

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
<div class="lb-trans">內部人士可能會獲得普通股東無法享受的可觀財務利益。
</div>The proposed transactions may contain terms that could limit superior competing offers.
<div class="lb-trans">擬議的交易可能包含限制更優競爭報價的條款。
</div>Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">鼓勵股東與本公司聯繫，討論他們的權利和選擇，且無需支付任何費用或義務。我們將以風險代理的方式處理任何事務，您無需承擔我們的法律費用或開支。
</div>NEW YORK
<div class="lb-trans">紐約
</div>May 12, 2026
<div class="lb-trans">2026 年 5 月 12 日
</div>Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)'s sale to Angelini Pharma S.p.A. for $31.50 per share in cash. If you are a Catalyst shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) 以每股 31.50 美元現金出售給 Angelini Pharma S.p.A. 如果您是 Catalyst 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>UniFirst Corporation (NYSE: UNF)'s sale to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock for each UniFirst share. If you are a UniFirst shareholder, click here to learn more about your rights and options .
<div class="lb-trans">UniFirst Corporation (NYSE: UNF) 以每股 155.00 美元現金和 0.7720 股 Cintas 股票出售給 Cintas Corporation。如果您是 UniFirst 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>RE/MAX Holdings, Inc. (NYSE: RMAX)'s sale to The Real Brokerage Inc. for either 5.152 shares of the combined company or $13.80 in cash per share. If you are a RE/MAX shareholder, click here to learn more about your rights and options .
<div class="lb-trans">RE/MAX Holdings, Inc. (NYSE: RMAX) 以每股 5.152 股合併公司的股票或每股 13.80 美元現金出售給 The Real Brokerage Inc. 如果您是 RE/MAX 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>ACRES Commercial Realty Corp. (NYSE: ACR)'s merger with ACRES Capital Corp. If you are an ACRES Commercial shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">ACRES Commercial Realty Corp. (NYSE: ACR) 與 ACRES Capital Corp. 合併。如果您是 ACRES Commercial 的股東， 請點擊這裏瞭解您的法律權利和選擇。
</div>On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.
<div class="lb-trans">代表股東，Halper Sadeh LLC 可能尋求增加對價、額外披露和信息，或其他救濟和利益。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律師廣告。以往的結果並不保證類似的結果。
</div>Contact Information:
<div class="lb-trans">聯繫信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>One World Trade Center
<div class="lb-trans">世界貿易中心一號
</div>85th Floor
<div class="lb-trans">85 層
</div>New York, NY 10007
<div class="lb-trans">紐約，NY 10007
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">來源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU2UFJfTkVXU19VU1BSX19fX19OWTU3MDY0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY57064&amp;Transmission_Id=202605120256PR_NEWS_USPR_____NY57064&amp;DateId=20260512"/>

02:56 ETAre CPRX, UNF, RMAX, ACR Obtaining Fair Deals for their Shareholders?

prnewswire

觸媒製藥公司、Unifirst、RE/MAX 控股和 ACRES Commercial Realty 是否為其股東爭取到了公平的交易？